Is second-line anti-tuberculosis drug susceptibility testing reliable?

Key operational challenges at a programmatic level to achieve optimal use of the GeneXpert platform.

IJTLD open·2026

Fifteen years of rifampicin-resistant TB control in Niger: high countrywide treatment uptake and success.

IJTLD open·2026

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.

IJTLD open·2025

Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB.

IJTLD open·2025

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.

Antimicrobial agents and chemotherapy·2025

Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.

Journal of clinical microbiology·2025

TB and mental health integration: lessons from WHO feasibility pilots in Ghana, Kenya, and Pakistan.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Comparing adherence strategies and facility DOT in TB care: a systematic review with meta-analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Evaluation of microscopically quantitative loads of bacilli as early predictors of TB treatment outcome.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Novel near-point-of-care TB molecular tests: navigating the repercussions of sensitivity tradeoffs.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Trends and treatment outcomes of TB among people living with HIV: a nationwide cohort study, 2011-2022.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Miliary TB - a retrospective cohort study of diagnostic and clinical features.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Genomic Characterization and Taxonomic Classification of Mycobacterium shunyiense sp. nov., a Novel Nontuberculous Mycobacterial Species from a Human Respiratory Specimen.

International journal of molecular sciences·2026

Preventive intrapulmonary treatment with Ligilactobacillus murinus reduces airway inflammation and mucus plugging in mice with cystic fibrosis-like lung disease.

ERJ open research·2026

Exploring the synergistic effect of Pseudomonas monteilii on the growth promotion of mangrove isolated cyanobacterium Leptolyngbya lignicola.

Archives of microbiology·2026

Giant Mesenteric Angioleiomyoma: A Rare Case Report.

Annals of African medicine·2026

Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.

CPT: pharmacometrics & systems pharmacology·2026

Integrated physiology, transcriptomics and targeted metabolomics reveal a potential quorum sensing network involved in the initial spore density-dependent regulation of morphogenesis and polyketide biosynthesis in Monascus.

International journal of food microbiology·2026

Related Experiment Videos

Is second-line anti-tuberculosis drug susceptibility testing reliable?

Related Concept Videos

Key operational challenges at a programmatic level to achieve optimal use of the GeneXpert platform.

Fifteen years of rifampicin-resistant TB control in Niger: high countrywide treatment uptake and success.

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.

Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB.

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.

Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.

TB and mental health integration: lessons from WHO feasibility pilots in Ghana, Kenya, and Pakistan.

Comparing adherence strategies and facility DOT in TB care: a systematic review with meta-analysis.

Evaluation of microscopically quantitative loads of bacilli as early predictors of TB treatment outcome.

Novel near-point-of-care TB molecular tests: navigating the repercussions of sensitivity tradeoffs.

Trends and treatment outcomes of TB among people living with HIV: a nationwide cohort study, 2011-2022.

Miliary TB - a retrospective cohort study of diagnostic and clinical features.

Genomic Characterization and Taxonomic Classification of Mycobacterium shunyiense sp. nov., a Novel Nontuberculous Mycobacterial Species from a Human Respiratory Specimen.

Preventive intrapulmonary treatment with Ligilactobacillus murinus reduces airway inflammation and mucus plugging in mice with cystic fibrosis-like lung disease.

Exploring the synergistic effect of Pseudomonas monteilii on the growth promotion of mangrove isolated cyanobacterium Leptolyngbya lignicola.

Giant Mesenteric Angioleiomyoma: A Rare Case Report.

Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.

Integrated physiology, transcriptomics and targeted metabolomics reveal a potential quorum sensing network involved in the initial spore density-dependent regulation of morphogenesis and polyketide biosynthesis in Monascus.

Related Experiment Videos

Is second-line anti-tuberculosis drug susceptibility testing reliable?

Related Concept Videos

Related Articles